In the univariate analysis, male sex, non-normal BMI (underweight or overweight), elevated baseline CEA levels ( ≥ 5 U/mL), poor tumor differentiation, FDG-PET avidity, and synchronous metastatic disease were associated with worse OS. This evidence concerns the gene CEACAM5 and metastatic neoplasm.